PACER ADVISORS, INC. Horizon Therapeutics Public Limited Company Transaction History

PACER ADVISORS, INC. portfolio value:

$37.70M
portfolio value

Horizon Therapeutics Public Limited Company 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 609.18K shares 37.70M $61.89 609.18K